Related Experiment Videos
Evolution of the maze III procedure: are modifications necessary?
1Division of Thoracic and Cardiovascular Surgery, LDS Hospital, Salt Lake City, Utah, USA.
The Thoracic and Cardiovascular Surgeon
|October 16, 1999
Summary
The Maze III procedure effectively treats supraventricular arrhythmias. This review examines its development, modifications, and outcomes, particularly when combined with mitral valve surgery.
Area of Science:
- Cardiac Surgery
- Electrophysiology
- Arrhythmia Management
Background:
- The Maze III procedure is a surgical technique for treating supraventricular arrhythmias.
- Numerous modifications exist, aiming to simplify the procedure, especially for patients with concomitant mitral valve disease.
- The original Maze III procedure is preferred by the authors for these complex cases.
Purpose of the Study:
- To review the evolution of the Maze III procedure and its modifications.
- To compare early outcomes of the original Maze III procedure versus modified approaches.
- To evaluate the Maze III procedure in patients undergoing concurrent mitral and other valvular surgeries.
Main Methods:
- Literature review tracking the development of the Maze III procedure.
- Comparative analysis of early outcomes reported in surgical series.
- Focus on patients with atrial fibrillation and valvular pathology.
Main Results:
- The original Maze III procedure has demonstrated success in curing atrial fibrillation.
- Modifications aim for procedural simplification but may impact efficacy.
- Early outcomes in patients combining Maze III with mitral valve procedures are analyzed.
Conclusions:
- The Maze III procedure remains a cornerstone for treating complex supraventricular arrhythmias.
- Unmodified Maze III is preferred for patients with significant valvular disease.
- Further comparison of outcomes between original and modified Maze III procedures is warranted.